Springer Daria Magdalena, Cofta Szczepan, Juszkat Robert, Żabicki Bartosz, Goździk-Spychalska Joanna, Nowicka Agata, Winiarska Hanna, Batura-Gabryel Halina
Department of Respiratory Medicine, Allergology and Pulmonary Oncology, Poznań University of Medical Sciences.
Adv Respir Med. 2018;86(5):220-226. doi: 10.5603/ARM.2018.0035.
Bronchial artery embolisation (BAE) is one of the methods used in massive and recurring haemoptysis. The aim of the study is to determine the effectiveness and complications of bronchial artery embolisation in recurring haemoptysis.
The analysis included 47 embolisation procedures performed on 30 patients treated between 2011 and 2017 in the Department of Respiratory Medicine, Allergology and Pulmonary Oncology due to haemoptysis. The patient's age ranged between 18 and 71 years, while mean age at the time of BAE was 33.5 years. Patients with tuberculosis constituted 73.33% (n = 22) of the sample and underwent 31 embolisation procedures in total. The remaining part of the sample (n = 8) collectively underwent 16 BAEs. The analysis was conducted by verifying the medical documentation, as well as carrying face-to-face and phone conversations.
Immediate control due to the inhibition of bleeding was obtained in 95.75% of cases. Recurrence within 3 days of BAE was reported in 5 patients (10.63%), and 4 re-embolisation procedures were conducted. In 10 patients (33.33%), recurrence was observed during the first year post-BAE, while it was reported in 17 cases during the whole observation period (56.66% of patients). The subjects who underwent re-embolisation demonstrated recurrence-free periods lasting from 2 days to 63 months. In patients with recurrence but no re-embolisation, the shortest and longest haemoptysis-free time was 2 and 35 months, respectively. 11 patients (36.66%) required several embolisation procedures during the whole observation period.
BAE is a highly successful procedure in treating haemoptysis. The risk of complications is low.
支气管动脉栓塞术（BAE）是用于治疗大量咯血和复发性咯血的方法之一。本研究的目的是确定支气管动脉栓塞术治疗复发性咯血的有效性和并发症。
分析包括2011年至2017年期间在呼吸内科、变态反应科和肺肿瘤科因咯血接受治疗的30例患者所进行的47次栓塞手术。患者年龄在18至71岁之间，BAE时的平均年龄为33.5岁。结核病患者占样本的73.33%（n = 22），共接受了31次栓塞手术。样本的其余部分（n = 8）共接受了16次BAE。通过查阅医疗记录以及进行面对面和电话交谈来进行分析。
95.75%的病例因出血得到抑制而立即得到控制。5例患者（10.63%）在BAE后3天内复发，进行了4次再次栓塞手术。10例患者（33.33%）在BAE后第一年内复发，而在整个观察期内有17例复发（占患者的56.66%）。接受再次栓塞的患者无复发期持续2天至63个月。在复发但未进行再次栓塞的患者中，咯血停止的最短和最长时间分别为2个月和35个月。11例患者（36.66%）在整个观察期内需要进行多次栓塞手术。
BAE是治疗咯血的一种非常成功的手术。并发症风险较低。
